[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2125696T3 - Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales. - Google Patents

Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.

Info

Publication number
ES2125696T3
ES2125696T3 ES96118939T ES96118939T ES2125696T3 ES 2125696 T3 ES2125696 T3 ES 2125696T3 ES 96118939 T ES96118939 T ES 96118939T ES 96118939 T ES96118939 T ES 96118939T ES 2125696 T3 ES2125696 T3 ES 2125696T3
Authority
ES
Spain
Prior art keywords
dysfunctions
treatment
tropsy
vesic
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96118939T
Other languages
English (en)
Inventor
Ulrich Dr Rer Nat Schwantes
Albert Schaupp
Manfred Dr Med Habil Stohrer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfleger R Chemische Fabrik GmbH
Original Assignee
Pfleger R Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2125696(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfleger R Chemische Fabrik GmbH filed Critical Pfleger R Chemische Fabrik GmbH
Application granted granted Critical
Publication of ES2125696T3 publication Critical patent/ES2125696T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

USO DE CLORURO DE TROSPIO PARA LA PRODUCCION DE UNA PREPARACION MEDICAMENTOSA BASADA EN UNA DISOLUCION ACUOSA ESTERIL EN EL TRATAMIENTO DE TRASTORNOS DE LA FUNCION DE LA VEJIGA DE LA ORINA Y DEL SISTEMA URINARIO, CARACTERIZADO POR LA APLICACION INTRAVESICAL MEDIANTE UN CATETER DIRECTAMENTE EN EL INTERIOR DE LA VEJIGA, DONDE LA DISOLUCION ACUOSA SE PREPARA CON UN PH DE 4,5 ANTES DE LA APLICACION Y EL SISTEMA CORRESPONDIENTE DE 2 COMPONENTES.
ES96118939T 1996-11-27 1996-11-27 Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales. Expired - Lifetime ES2125696T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96118939A EP0856312B1 (de) 1996-11-27 1996-11-27 Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten

Publications (1)

Publication Number Publication Date
ES2125696T3 true ES2125696T3 (es) 1999-03-01

Family

ID=8223435

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96118939T Expired - Lifetime ES2125696T3 (es) 1996-11-27 1996-11-27 Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.

Country Status (8)

Country Link
US (1) US5998430A (es)
EP (1) EP0856312B1 (es)
JP (1) JPH10158169A (es)
AT (1) ATE172117T1 (es)
CA (1) CA2221900C (es)
DE (1) DE59600683D1 (es)
DK (1) DK0856312T3 (es)
ES (1) ES2125696T3 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60026704T2 (de) * 1999-07-01 2006-10-19 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetine zur Behandlung chronischer Schmerzen
US6974820B2 (en) * 2002-11-06 2005-12-13 Bridge Pharma, Inc. Methods for treating urinary incontinence and other disorders using trospium
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
EP1622450A4 (en) * 2003-04-25 2009-11-18 Endo Pharmaceuticals Solutions PROCESS FOR PROMOTING UNINTERRUPTED SLEEP BY ADMINISTERING TROPIUM CHLORIDE
EP1680100A4 (en) 2003-11-04 2012-08-08 Supernus Pharmaceuticals Inc QUATERNARY AMMONIUM COMPOUNDS CONTAINING BIOAVAILABILITY ACTIVATORS
AU2004289223B2 (en) * 2003-11-04 2009-11-05 Supernus Pharmaceuticals, Inc. Once daily dosage forms of trospium
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE602004020337D1 (de) * 2004-08-11 2009-05-14 Boehringer Ingelheim Pharma Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege
US20060287347A1 (en) * 2005-06-21 2006-12-21 Aberg A K G Methods for treating smooth muscle disorders using trospium
US7390816B2 (en) * 2005-06-21 2008-06-24 Bridge Pharma, Inc. Methods for treating urinary incontinence in patients suffering from memory disorders
US20070004766A1 (en) * 2005-07-01 2007-01-04 Aberg A K G Methods for relaxation of smooth muscle contractions using Trospium
NZ566577A (en) * 2005-08-15 2011-04-29 Boehringer Ingelheim Int Methods for producing betamimetics
WO2008019070A2 (en) * 2006-08-04 2008-02-14 Ebrahim Versi Pharmaceutical compositions of trospium for treating smooth muscle hyperactivity disorders
EP2897616A1 (en) * 2012-09-18 2015-07-29 TARIS Biomedical LLC Drug delivery systems and methods for treatment of bladder voiding dysfunction!and other lower urinary tract disorders by using trospium
CN112839653A (zh) 2018-08-01 2021-05-25 塔里斯生物医药公司 使用曲司氯铵治疗膀胱过度活动症的方法
KR20230012471A (ko) 2020-03-30 2023-01-26 트리젤 엘티디. 암 치료용 조성물 및 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1194422B (de) 1963-03-05 1965-06-10 Robert Pfleger Chem Fab Dr Verfahren zur Herstellung von Azoniaspironortropanderivaten
DE3546165A1 (de) * 1985-12-27 1987-10-15 Madaus & Co Dr Verwendung von azoniaspironortropanolestern als asthmatherapeutikum und als broncholytikum

Also Published As

Publication number Publication date
DK0856312T3 (da) 1999-06-23
DE59600683D1 (de) 1998-11-19
US5998430A (en) 1999-12-07
ATE172117T1 (de) 1998-10-15
CA2221900C (en) 2007-10-23
CA2221900A1 (en) 1998-05-27
JPH10158169A (ja) 1998-06-16
EP0856312B1 (de) 1998-10-14
EP0856312A1 (de) 1998-08-05

Similar Documents

Publication Publication Date Title
ES2125696T3 (es) Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
BR9702362A (pt) Novas fomrulações lìquidas estáveis à base de paracetamol e seu modo de preparação.
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
GEP20043354B (en) Therapeutic Formulation for Administering Tolterodine with Controlled Release
ES2136618T3 (es) Cicatrizacion de heridas.
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
BR0116293A (pt) Composição tópica, e, método para prevenir, melhorar ou tratar a hiperpigmentação da pele
HUP0202776A2 (hu) (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
KR910005858A (ko) 지방산 요법
US5278172A (en) Method and composition for treating tendon or joint inflammation using a vasodilator
PT1251850E (pt) Utilizacao de uma preparacao de combinacao na terapia do cancro
BR9603454A (pt) Composição e método para tratamento de câncer de próstata
ES2139774T3 (es) Uso de una combinacion de antineoplastones en la preparacion de un medicamento para el tratamiento de la neurofibromatosis.
KR920703060A (ko) 제약학적 배합물
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 856312

Country of ref document: ES